Nectin Therapeutics is based in Fort Lee. It has raised $25M in total funding. Latest round: Series A.
Nectin Therapeutics is based in Fort Lee. Nectin Therapeutics has raised $25M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2024. The round record for Nectin Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Israel Biotech Fund (IBF), Peregrine Ventures, aMoon Fund, Guangzhou-Israel Biotechnology Fund (GIBF), Cancer Focus Fund, Integra Holdings. 6 distinct backers are named across the disclosed rounds.
We update the Nectin Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Fort Lee and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026